Skip to content

Clinical trials

Phase 3 Renal Insufficiency trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency Phase: Phase 3 Clear all

129 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20022
20038
20045
20054
20067
20072
20089
20098
201010
20116
201212
20135
20146
20156
20166
20173
20181
20196
20201
20223
20235
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed103
Terminated11
Unknown status6
Active, not recruiting3
Recruiting3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc6
Scios, Inc.6
Veloxis Pharmaceuticals5
Akebia Therapeutics4
Daiichi Sankyo Co., Ltd.4
NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)3
Novartis Pharmaceuticals3
AbbVie2
Amgen2
AstraZeneca2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency129
Renal Insufficiency, Chronic26
Kidney Failure, Chronic22
Heart Failure16
Kidney Diseases16
Anemia13
Hyperphosphatemia11
Diabetes Mellitus, Type 29
Cardiomyopathies6
Fibrosis4

Trials

Showing 76 to 100 of 129. Each trial links to its page on Pharma Observatory.

29 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.